更多...
收起
This gene product is a protein tyrosine kinase involved in a specific subset of cytokine receptor signaling pathways. It has been found to be constituitively associated with the prolactin receptor and is required for responses to gamma interferon. Mice that do not express an active protein for this gene exhibit embryonic lethality associated with the absence of definitive erythropoiesis. [provided by RefSeq, Jul 2008]
[中文简述(自动翻译):]  该基因产物是一种参与细胞因子受体信号通路的特定子集的蛋白酪氨酸激酶。已发现与催乳素受体被constituitively相关联,并且需要到γ干扰素应答。小鼠不表达与不存在明确的红细胞生成的关联该基因表现出胚胎致死的活性的蛋白质。 [由RefSeq的,2008年7月提供]
JAK2基因(以及对应的蛋白质)的细胞分布位置:
JAK2基因的本体(GO)信息:
| 疾病名称 | 关系值 | NofPmids | NofSnps | 来源 |
| Polycythemia Vera | 0.666276895 | 365 | 3 | BeFree_CTD_human_GAD_LHGDN_MGD_ORPHANET_UNIPROT |
| Thrombocythemia, Essential | 0.461781343 | 291 | 6 | BeFree_CTD_human_GAD_LHGDN_ORPHANET |
| Myeloproliferative disease | 0.351660654 | 325 | 5 | BeFree_CTD_human_GAD_LHGDN |
| Primary Myelofibrosis | 0.294051045 | 271 | 8 | BeFree_CTD_human_GAD_LHGDN |
| Leukemia, Myelocytic, Acute | 0.284782823 | 46 | 3 | BeFree_CTD_human_GAD_LHGDN_UNIPROT |
| Budd-Chiari Syndrome | 0.255721222 | 18 | 2 | BeFree_CTD_human_GAD_LHGDN_ORPHANET |
| Myelofibrosis | 0.22904428 | 107 | 2 | BeFree_MGD_ORPHANET |
| Thrombocytosis | 0.164325815 | 46 | 4 | BeFree_CTD_human_GAD_LHGDN |
| Venous Thrombosis | 0.160016421 | 16 | 0 | CTD_human_GAD_LHGDN |
| Polycythemia | 0.149484932 | 44 | 4 | BeFree_CTD_human_GAD_LHGDN |
| leukemia | 0.144970109 | 34 | 2 | BeFree_CTD_human_GAD_LHGDN |
| Ulcerative Colitis | 0.131368221 | 12 | 4 | BeFree_CTD_human_GAD |
| Pregnancy Complications | 0.125362824 | 3 | 0 | BeFree_CTD_human_GAD_LHGDN |
| Thromboembolism | 0.124895885 | 9 | 2 | BeFree_CTD_human_LHGDN |
| Myocardial Ischemia | 0.120271442 | 3 | 2 | BeFree_CTD_human |
| Spontaneous abortion | 0.12 | 1 | 0 | CTD_human |
| Calcinosis | 0.12 | 1 | 0 | CTD_human |
| Heart valve disease | 0.12 | 1 | 0 | CTD_human |
| Mesenteric Vascular Occlusion | 0.12 | 1 | 0 | CTD_human |
| Prostatic Neoplasms | 0.12 | 1 | 0 | CTD_human |
| THROMBOCYTHEMIA 3 | 0.12 | 2 | 0 | UNIPROT |
| Cerebrovascular accident | 0.085634266 | 4 | 2 | BeFree_GAD_LHGDN_RGD |
| Thrombosis | 0.084186466 | 30 | 0 | GAD_LHGDN |
| Obesity | 0.082909916 | 4 | 0 | BeFree_GAD_RGD |
| Diabetic Nephropathy | 0.080271442 | 2 | 0 | BeFree_RGD |
| Transient Ischemic Attack | 0.08 | 1 | 0 | RGD |
| Growth Disorders | 0.08 | 1 | 0 | RGD |
| Heart Diseases | 0.08 | 1 | 0 | RGD |
| Hyperalgesia | 0.08 | 1 | 0 | RGD |
| Biliary cirrhosis | 0.08 | 1 | 0 | RGD |
| Liver Cirrhosis, Experimental | 0.08 | 1 | 0 | RGD |
| Myocardial Infarction | 0.08 | 1 | 0 | RGD |
| Myocardial Reperfusion Injury | 0.08 | 2 | 0 | RGD |
| Retinal Detachment | 0.08 | 1 | 0 | RGD |
| Sepsis | 0.08 | 1 | 0 | RGD |
| Sepsis-Associated Encephalopathy | 0.08 | 1 | 0 | RGD |
| Non-alcoholic Fatty Liver Disease | 0.08 | 1 | 0 | RGD |
| Hyperuricemia | 0.08 | 1 | 0 | RGD |
| Arthritis, Experimental | 0.08 | 2 | 0 | RGD |
| THROMBOCYTHEMIA 1 | 0.08 | 0 | 0 | MGD |
| Chronic myeloproliferative disorder | 0.046145118 | 170 | 4 | BeFree |
| MYELODYSPLASTIC SYNDROME | 0.020465218 | 11 | 2 | BeFree_GAD_LHGDN |
| Myeloid Leukemia | 0.01801231 | 11 | 2 | BeFree_GAD_LHGDN |
| Myeloid Leukemia, Chronic | 0.015873112 | 34 | 2 | BeFree_GAD_LHGDN |
| Leukocytosis | 0.015274147 | 5 | 0 | GAD_LHGDN |
| Down Syndrome | 0.01507865 | 9 | 0 | BeFree_GAD_LHGDN |
| Precursor Cell Lymphoblastic Leukemia Lymphoma | 0.014439958 | 20 | 2 | BeFree_GAD_LHGDN |
| Crohn Disease | 0.014006695 | 12 | 3 | BeFree_GAD |
| Thrombophilia | 0.014006695 | 11 | 2 | BeFree_GAD |
| Hematologic Neoplasms | 0.013615701 | 27 | 3 | BeFree_GAD |
| Leukemia, Myelomonocytic, Chronic | 0.012811307 | 14 | 2 | BeFree_GAD_LHGDN |
| Refractory anemias | 0.011354408 | 6 | 2 | BeFree_GAD_LHGDN |
| Erythrocytosis | 0.009967404 | 28 | 2 | BeFree_GAD |
| Venous Thromboembolism | 0.009825446 | 4 | 0 | GAD_LHGDN |
| Hodgkin Disease | 0.007620235 | 9 | 2 | BeFree_LHGDN |
| Chronic Lymphocytic Leukemia | 0.007348794 | 9 | 2 | BeFree_LHGDN |
| B-Cell Lymphomas | 0.006534468 | 6 | 0 | BeFree_LHGDN |
| Inflammatory Bowel Diseases | 0.006448592 | 6 | 0 | BeFree_GAD_LHGDN |
| Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 0.006263026 | 4 | 2 | BeFree_LHGDN |
| Blast Phase | 0.006091273 | 6 | 2 | BeFree_GAD |
| Mammary Neoplasms | 0.005991584 | 4 | 0 | BeFree_LHGDN |
| Lymphoma | 0.005895776 | 14 | 2 | BeFree_GAD |
| Thrombocytopenia | 0.0054487 | 2 | 0 | LHGDN |
| Acute lymphocytic leukemia | 0.005428837 | 20 | 2 | BeFree |
| Sideroblastic anemia | 0.005091382 | 2 | 0 | GAD_LHGDN |
| Pancreatic Neoplasm | 0.005091382 | 2 | 0 | GAD_LHGDN |
| Ankylosing spondylitis | 0.005005506 | 2 | 0 | BeFree_GAD |
| Neoplastic Cell Transformation | 0.004734064 | 2 | 0 | GAD |
| Pathologic Neovascularization | 0.004734064 | 2 | 0 | GAD |
| Vascular Diseases | 0.004734064 | 2 | 0 | GAD |
| Genomic Instability | 0.004734064 | 2 | 0 | GAD |
| Splanchnic vein thrombosis | 0.004734064 | 2 | 0 | GAD |
| Multiple Myeloma | 0.00408156 | 6 | 2 | BeFree_LHGDN |
| Mastocytosis, Systemic | 0.00408156 | 5 | 2 | BeFree_LHGDN |
| Acute Erythroblastic Leukemia | 0.003810118 | 5 | 2 | BeFree_LHGDN |
| melanoma | 0.003810118 | 5 | 3 | BeFree_LHGDN |
| Juvenile Myelomonocytic Leukemia | 0.003538676 | 4 | 2 | BeFree_LHGDN |
| Hepatic Vein Thrombosis | 0.003528744 | 13 | 2 | BeFree |
| Acute leukemia | 0.003528744 | 13 | 2 | BeFree |
| Preleukemia | 0.003452799 | 5 | 2 | BeFree_GAD |
| Malignant neoplasm of breast | 0.003257302 | 12 | 0 | BeFree |
| Precursor B-cell lymphoblastic leukemia | 0.003257302 | 12 | 0 | BeFree |
| Lymphoproliferative Disorders | 0.003181358 | 4 | 2 | BeFree_GAD |
| Deep Vein Thrombosis | 0.003181358 | 4 | 2 | BeFree_GAD |
| Atherosclerosis | 0.002995792 | 1 | 0 | BeFree_LHGDN |
| Renal Cell Carcinoma | 0.002995792 | 2 | 0 | BeFree_LHGDN |
| Glioma | 0.002995792 | 2 | 0 | BeFree_LHGDN |
| Activated Protein C Resistance | 0.002995792 | 2 | 2 | BeFree_LHGDN |
| Breast Carcinoma | 0.002985861 | 11 | 0 | BeFree |
| Anoxia | 0.00272435 | 1 | 0 | LHGDN |
| Choriocarcinoma | 0.00272435 | 1 | 0 | LHGDN |
| Colonic Neoplasms | 0.00272435 | 1 | 0 | LHGDN |
| Hypersensitivity | 0.00272435 | 1 | 0 | LHGDN |
| Disease Progression | 0.00272435 | 1 | 0 | LHGDN |
| Constitutional Symptom | 0.002442977 | 9 | 2 | BeFree |
| Malignant neoplasm of stomach | 0.002442977 | 9 | 2 | BeFree |
| Stomach Carcinoma | 0.002442977 | 9 | 2 | BeFree |
| CAMPOMELIC DYSPLASIA | 0.002442977 | 9 | 2 | BeFree |
| Arterial Occlusive Diseases | 0.002367032 | 1 | 0 | GAD |
| Asthma | 0.002367032 | 1 | 0 | GAD |
| Bronchiolitis, Viral | 0.002367032 | 1 | 0 | GAD |
| Chromosome Aberrations | 0.002367032 | 1 | 0 | GAD |
| DNA Damage | 0.002367032 | 1 | 0 | GAD |
| Hemorrhage | 0.002367032 | 1 | 0 | GAD |
| Insulin Resistance | 0.002367032 | 1 | 0 | GAD |
| Multiple Sclerosis | 0.002367032 | 1 | 0 | GAD |
| Pulmonary Embolism | 0.002367032 | 1 | 0 | GAD |
| Respiratory Syncytial Virus Infections | 0.002367032 | 1 | 0 | GAD |
| Splenomegaly | 0.002367032 | 1 | 0 | GAD |
| Tobacco Use Disorder | 0.002367032 | 1 | 0 | GAD |
| Chromosomal translocation | 0.002367032 | 1 | 0 | GAD |
| Trisomy | 0.002367032 | 1 | 0 | GAD |
| Viremia | 0.002367032 | 1 | 0 | GAD |
| Iron deficiency anemia | 0.002367032 | 1 | 0 | GAD |
| Hepatitis B, Chronic | 0.002367032 | 1 | 0 | GAD |
| Portal vein thrombosis | 0.002171535 | 8 | 2 | BeFree |
| Malignant neoplasm of prostate | 0.002171535 | 8 | 2 | BeFree |
| Prostate carcinoma | 0.002171535 | 8 | 2 | BeFree |
| Secondary polycythemia | 0.002171535 | 8 | 2 | BeFree |
| secondary myelofibrosis | 0.001900093 | 7 | 2 | BeFree |
| Neoplasm, Residual | 0.001900093 | 7 | 2 | BeFree |
| Carcinogenesis | 0.001900093 | 7 | 2 | BeFree |
| Myeloid neoplasm | 0.001900093 | 7 | 2 | BeFree |
| Hematological Disease | 0.001628651 | 6 | 2 | BeFree |
| Pruritus | 0.001628651 | 6 | 2 | BeFree |
| Thrombosis of cerebral veins | 0.001628651 | 6 | 2 | BeFree |
| Anemia | 0.001357209 | 5 | 3 | BeFree |
| Mesenteric Venous Thrombosis | 0.001357209 | 5 | 2 | BeFree |
| Leukemogenesis | 0.001357209 | 5 | 0 | BeFree |
| Eosinophilic disorder | 0.001357209 | 5 | 3 | BeFree |
| Classical Hodgkin's Lymphoma | 0.001357209 | 5 | 0 | BeFree |
| Autoimmune Diseases | 0.001085767 | 4 | 0 | BeFree |
| Malignant tumor of colon | 0.001085767 | 4 | 0 | BeFree |
| Colorectal Carcinoma | 0.001085767 | 4 | 0 | BeFree |
| Eosinophilia | 0.001085767 | 4 | 3 | BeFree |
| Acute Megakaryocytic Leukemias | 0.001085767 | 4 | 2 | BeFree |
| Chronic Neutrophilic Leukemia | 0.001085767 | 4 | 2 | BeFree |
| Myeloid Metaplasia | 0.001085767 | 4 | 2 | BeFree |
| Ovarian Carcinoma | 0.001085767 | 4 | 0 | BeFree |
| Supraventricular tachycardia | 0.001085767 | 4 | 2 | BeFree |
| Arterial thrombosis | 0.001085767 | 4 | 2 | BeFree |
| Chronic eosinophilic leukemia | 0.001085767 | 4 | 2 | BeFree |
| Colon Carcinoma | 0.001085767 | 4 | 0 | BeFree |
| Mediastinal (Thymic) Large B-Cell Lymphoma | 0.001085767 | 4 | 2 | BeFree |
| Colorectal Cancer | 0.001085767 | 4 | 0 | BeFree |
| Disorder characterized by eosinophilia | 0.001085767 | 4 | 3 | BeFree |
| Liver carcinoma | 0.001085767 | 4 | 0 | BeFree |
| Congenital chromosomal disease | 0.000814326 | 3 | 0 | BeFree |
| Subacute Bacterial Endocarditis | 0.000814326 | 3 | 2 | BeFree |
| Diffuse Large B-Cell Lymphoma | 0.000814326 | 3 | 0 | BeFree |
| Female Pseudohermaphroditism | 0.000814326 | 3 | 2 | BeFree |
| Solid tumour | 0.000814326 | 3 | 0 | BeFree |
| Hematopoietic Neoplasms | 0.000814326 | 3 | 0 | BeFree |
| Squamous cell carcinoma of the head and neck | 0.000814326 | 3 | 0 | BeFree |
| Xenograft Model | 0.000814326 | 3 | 2 | BeFree |
| CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT | 0.000814326 | 3 | 2 | BeFree |
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 0.000814326 | 3 | 0 | BeFree |
| Refractory anemia, without ringed sideroblasts, without excess blasts | 0.000814326 | 3 | 2 | BeFree |
| Astrocytoma | 0.000542884 | 2 | 0 | BeFree |
| Non-Small Cell Lung Carcinoma | 0.000542884 | 2 | 0 | BeFree |
| Coronary Arteriosclerosis | 0.000542884 | 2 | 2 | BeFree |
| Fanconi Anemia | 0.000542884 | 2 | 0 | BeFree |
| Leukemia, T-Cell | 0.000542884 | 2 | 0 | BeFree |
| Leukopenia | 0.000542884 | 2 | 0 | BeFree |
| Neoplasm Metastasis | 0.000542884 | 2 | 0 | BeFree |
| Psoriasis | 0.000542884 | 2 | 0 | BeFree |
| Severe Combined Immunodeficiency | 0.000542884 | 2 | 0 | BeFree |
| Monocytosis | 0.000542884 | 2 | 0 | BeFree |
| Small cell carcinoma of lung | 0.000542884 | 2 | 0 | BeFree |
| Familial erythrocytosis | 0.000542884 | 2 | 0 | BeFree |
| Granulocytic Sarcoma | 0.000542884 | 2 | 2 | BeFree |
| Tumor Progression | 0.000542884 | 2 | 2 | BeFree |
| Idiopathic Hypereosinophilic Syndrome | 0.000542884 | 2 | 2 | BeFree |
| Pancreatic carcinoma | 0.000542884 | 2 | 0 | BeFree |
| Disseminated eosinophilic collagen disease | 0.000542884 | 2 | 2 | BeFree |
| secondary acute myeloid leukemia | 0.000542884 | 2 | 2 | BeFree |
| Malignant neoplasm of pancreas | 0.000542884 | 2 | 0 | BeFree |
| Reactive thrombocytosis | 0.000542884 | 2 | 0 | BeFree |
| Hypereosinophilia | 0.000542884 | 2 | 3 | BeFree |
| Myelosuppression | 0.000542884 | 2 | 0 | BeFree |
| Malignant neoplasm of ovary | 0.000542884 | 2 | 0 | BeFree |
| Myelodysplastic Syndrome with Isolated del(5q) | 0.000542884 | 2 | 2 | BeFree |
| Mammary Tumorigenesis | 0.000542884 | 2 | 0 | BeFree |
| Hypereosinophilic syndrome | 0.000542884 | 2 | 2 | BeFree |
| Extramedullary Hematopoiesis (disorder) | 0.000542884 | 2 | 2 | BeFree |
| FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) | 0.000542884 | 2 | 0 | BeFree |
| Neutrophilia (disorder) | 0.000542884 | 2 | 2 | BeFree |
| Adjustment Disorders | 0.000271442 | 1 | 2 | BeFree |
| Alzheimer's Disease | 0.000271442 | 1 | 0 | BeFree |
| Arteriosclerosis | 0.000271442 | 1 | 0 | BeFree |
| Arthritis, Adjuvant-Induced | 0.000271442 | 1 | 0 | BeFree |
| Behcet Syndrome | 0.000271442 | 1 | 0 | BeFree |
| Blood Coagulation Disorders | 0.000271442 | 1 | 2 | BeFree |
| Brain Neoplasms | 0.000271442 | 1 | 0 | BeFree |
| Squamous cell carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Central Retinal Artery Occlusion | 0.000271442 | 1 | 0 | BeFree |
| Malignant tumor of cervix | 0.000271442 | 1 | 0 | BeFree |
| Diabetes Mellitus, Insulin-Dependent | 0.000271442 | 1 | 0 | BeFree |
| Diabetes Mellitus, Non-Insulin-Dependent | 0.000271442 | 1 | 0 | BeFree |
| Ependymoma | 0.000271442 | 1 | 0 | BeFree |
| Hyperplasia erythroid | 0.000271442 | 1 | 2 | BeFree |
| Esophageal Neoplasms | 0.000271442 | 1 | 0 | BeFree |
| Glioblastoma | 0.000271442 | 1 | 0 | BeFree |
| Focal glomerulosclerosis | 0.000271442 | 1 | 2 | BeFree |
| Glycogen Storage Disease Type VI | 0.000271442 | 1 | 2 | BeFree |
| Graft-vs-Host Disease | 0.000271442 | 1 | 0 | BeFree |
| Hepatitis A | 0.000271442 | 1 | 0 | BeFree |
| Hyperinsulinism | 0.000271442 | 1 | 0 | BeFree |
| Pulmonary Hypertension | 0.000271442 | 1 | 0 | BeFree |
| Immunologic Deficiency Syndromes | 0.000271442 | 1 | 0 | BeFree |
| Ischemia | 0.000271442 | 1 | 0 | BeFree |
| Lymphoid leukemia | 0.000271442 | 1 | 0 | BeFree |
| Leukemia, Lymphocytic, Acute, L1 | 0.000271442 | 1 | 0 | BeFree |
| Liver Cirrhosis | 0.000271442 | 1 | 0 | BeFree |
| Liver diseases | 0.000271442 | 1 | 2 | BeFree |
| Lung Neoplasms | 0.000271442 | 1 | 0 | BeFree |
| Mastocytosis | 0.000271442 | 1 | 2 | BeFree |
| Meningioma | 0.000271442 | 1 | 0 | BeFree |
| Neuroblastoma | 0.000271442 | 1 | 0 | BeFree |
| Neurofibromatosis 1 | 0.000271442 | 1 | 2 | BeFree |
| Neutropenia | 0.000271442 | 1 | 0 | BeFree |
| Osteosarcoma | 0.000271442 | 1 | 0 | BeFree |
| Retinal Vein Occlusion | 0.000271442 | 1 | 2 | BeFree |
| Seizures | 0.000271442 | 1 | 0 | BeFree |
| Sezary Syndrome | 0.000271442 | 1 | 0 | BeFree |
| Dermatologic disorders | 0.000271442 | 1 | 0 | BeFree |
| Uveomeningoencephalitic Syndrome | 0.000271442 | 1 | 0 | BeFree |
| T-Cell Lymphoma | 0.000271442 | 1 | 0 | BeFree |
| Lymphoma, T-Cell, Cutaneous | 0.000271442 | 1 | 0 | BeFree |
| Peripheral Vascular Diseases | 0.000271442 | 1 | 2 | BeFree |
| Polyendocrinopathies, Autoimmune | 0.000271442 | 1 | 2 | BeFree |
| Amaurosis Fugax | 0.000271442 | 1 | 0 | BeFree |
| Deep thrombophlebitis | 0.000271442 | 1 | 0 | BeFree |
| Esophageal carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Idiopathic pulmonary hypertension | 0.000271442 | 1 | 0 | BeFree |
| Hyperparathyroidism, Primary | 0.000271442 | 1 | 0 | BeFree |
| acute aortic dissection | 0.000271442 | 1 | 0 | BeFree |
| Isochromosomes | 0.000271442 | 1 | 0 | BeFree |
| Parathyroid Adenoma | 0.000271442 | 1 | 0 | BeFree |
| Metastatic melanoma | 0.000271442 | 1 | 0 | BeFree |
| Philadelphia chromosome negative chronic myelogenous leukemia | 0.000271442 | 1 | 0 | BeFree |
| T-cell childhood acute lymphoblastic leukemia | 0.000271442 | 1 | 0 | BeFree |
| Squamous cell carcinoma of esophagus | 0.000271442 | 1 | 0 | BeFree |
| Gallbladder adenocarcinoma | 0.000271442 | 1 | 0 | BeFree |
| Cervix carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Acute panmyelosis with myelofibrosis | 0.000271442 | 1 | 0 | BeFree |
| Splenic atrophy | 0.000271442 | 1 | 0 | BeFree |
| Chronic liver disease | 0.000271442 | 1 | 2 | BeFree |
| Breast Cancer, Familial | 0.000271442 | 1 | 0 | BeFree |
| Helicobacter pylori (H. pylori) infection in conditions classified elsewhere and of unspecified site | 0.000271442 | 1 | 0 | BeFree |
| Chromosome 9, trisomy | 0.000271442 | 1 | 0 | BeFree |
| Chromosome 8, trisomy | 0.000271442 | 1 | 2 | BeFree |
| Recurrent tumor | 0.000271442 | 1 | 0 | BeFree |
| Malignant neoplasm of esophagus | 0.000271442 | 1 | 0 | BeFree |
| Osteosarcoma of bone | 0.000271442 | 1 | 0 | BeFree |
| Hyperhomocysteinemia | 0.000271442 | 1 | 2 | BeFree |
| Vascular Hemostatic Disorders | 0.000271442 | 1 | 2 | BeFree |
| Carcinoma of lung | 0.000271442 | 1 | 0 | BeFree |
| Central neuroblastoma | 0.000271442 | 1 | 0 | BeFree |
| 5q-syndrome | 0.000271442 | 1 | 2 | BeFree |
| Helicobacter pylori infection | 0.000271442 | 1 | 0 | BeFree |
| Philadelphia chromosome positive | 0.000271442 | 1 | 0 | BeFree |
| ovarian neoplasm | 0.000271442 | 1 | 0 | BeFree |
| Refractory anemia with ringed sideroblasts | 0.000271442 | 1 | 0 | BeFree |
| Chronic leukemia (category) | 0.000271442 | 1 | 0 | BeFree |
| Granulocytosis | 0.000271442 | 1 | 2 | BeFree |
| Myelodysplastic/myeloproliferative neoplasm, unclassifiable | 0.000271442 | 1 | 2 | BeFree |
| Mediastinal Lymphoma | 0.000271442 | 1 | 0 | BeFree |
| Mesenchymal Cell Neoplasm | 0.000271442 | 1 | 0 | BeFree |
| Nodular Lymphocyte Predominant Hodgkin Lymphoma | 0.000271442 | 1 | 0 | BeFree |
| Primary Myelofibrosis, Prefibrotic Stage | 0.000271442 | 1 | 2 | BeFree |
| Tumor Angiogenesis | 0.000271442 | 1 | 0 | BeFree |
| Glioblastoma Multiforme | 0.000271442 | 1 | 0 | BeFree |
| Cirrhosis | 0.000271442 | 1 | 0 | BeFree |
| Benign Prostatic Hyperplasia | 0.000271442 | 1 | 0 | BeFree |
| Peripheral Arterial Diseases | 0.000271442 | 1 | 2 | BeFree |
| Chromosome 5, trisomy 5q | 0.000271442 | 1 | 2 | BeFree |
| THROMBOPHILIA DUE TO ACTIVATED PROTEIN C RESISTANCE (disorder) | 0.000271442 | 1 | 2 | BeFree |
| Parvovirus B19 (disease) | 0.000271442 | 1 | 0 | BeFree |
| Philadelphia chromosome-positive acute lymphoblastic leukemia | 0.000271442 | 1 | 0 | BeFree |
| Leukemia, B-Cell | 0.000271442 | 1 | 0 | BeFree |
| Nasopharyngeal carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Pulmonary arterial hypertension | 0.000271442 | 1 | 0 | BeFree |
| Homocysteinemia | 0.000271442 | 1 | 2 | BeFree |
| Pulmonary Hypertension, Primary, 1, With Hereditary Hemorrhagic Telangiectasia | 0.000271442 | 1 | 0 | BeFree |
| Core binding factor acute myeloid leukemia | 0.000271442 | 1 | 0 | BeFree |
| Cytogenetically normal acute myeloid leukemia | 0.000271442 | 1 | 0 | BeFree |
忘记密码? 点击找回密码.
扫一扫右方二维码,关注微信订阅号,实时查看信息,关注医学生物学动态。